IFNG and Alzheimer disease: As expected, prototypical proinflammatory mediators IL-17 A, IFN-γ, TNF, VEGF-A, CCL7 and IL-12B, which are known to promote disease progression in Pso15,16, were significantly upregulated in Pso but not in AD (Fig. 1B).